Nectero Medical
Dover, US · Founded 2017
Biotech
Founders & leadership
JS
John SpringerExecutive Officer, Director
BR
Bruce RobertsDirector
Reported raises · per SEC filings
Form D private placements$32.8MraisedMay 2024 · 30 investors · Biotechnology
Rule 506(b)$18.2MraisedSep 2021 · 31 investors · Biotechnology
Rule 506(b)$1.5MofferedApr 2020 · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.